
Excited to share our latest work published today in @NatImmunol! 🎉 Together with Taja Vatovec, we investigated how somatic CBL deficiency affects B cell development and function. nature.com/articles/s41590-0…

Postdoc @bloodgenes @bostonchildrens 🇺🇸 | PhD @casanova_lab @institutimagine 🇫🇷 | Immunologist studying human genetics |

Excited to share our latest work published today in @NatImmunol! 🎉 Together with Taja Vatovec, we investigated how somatic CBL deficiency affects B cell development and function. nature.com/articles/s41590-0…

This review by @ALNeehus, @bloodgenes, @casanova_lab and @BustamanteJaci1 covers the human genetic defects affecting the phagocytic respiratory burst, highlighting the dichotomy between defects of the core NADPH oxidase and of upstream regulators. hubs.la/Q04xS9Y80

Huge thanks to my mentor @bloodgenes as well as @LWahlster and @jung_lee6151 with whom I co-led these studies. Thanks to all the great collaborators including @GauravA_UK @chenweng1991 @Spencer2268 @lrbzldz @dellaVolpe_L @CohnOfir @michaelpoeschla @adamdesmith @tjflemin

Deletion of ELK3 through CRISPR/Cas9 in our in vitro B cell culture system, revealed impaired B cell differentiation upon ELK3 KO as well as downregulation of B-celll progenitor drivers and signatures. This establishes ELK3 as a novel regulator of human B-cell development.

We further characterized a risk variant at the ELK3 locus that leads to increased chromatin accessibility and ELK3 expression. Overexpression of ELK3 in REH cells resulted in upregulation of genes associated with leukemia stem cell and B-ALL signatures.

To link regulatory variants to target genes, we analyzed long-range CRE-gene associations, identifying 34 high confidence target genes of which most where connected to progenitor-specific regulatory elements and enriched in critical components of B-cell development.

Correlating TRS with pathway signature scores identified B cell differentiation and activation as the biological processes most strongly associated with B-ALL risk, as well as signatures of V(D)J recombination.

In the second study, together with @jung_lee6151, we looked at common B-ALL GWAS variants. Statistical fine-mapping with joint single-cell multiomic, revealed a strong enrichment for GWAS variants at early stages of B cell development.

These developmental arrests were happening at states in which RAG1 and RAG2 are most active, supporting the idea that prolonged residence in RAG active stages increased the risk for abnormal RAG activity outside the V(D)J locus that could drive leukemic transformation.

We could show that most B-ALL predisposition genes resulted in early differentiation blocks along the B cell developmental trajectory, dependent on the gene disrupted and type of variant created.

We used CRISPR/Cas9 to model nine B-ALL predispositions genes, in which LOF variants have been shown to underlie familial cases of B-ALL, and combined this with single cell RNA-sequencing to look at B cell development at high resolution.

This system enriches for early B cell progenitor populations that are typically very rare in bone marrow samples. We show that these cells do not only express typical B lineage markers but also faithfully undergo V(D)J recombination during development.

In the first study, together with @LWahlster and @jung_lee6151 , we looked at rare, highly penetrant familial variants in an in vitro model of B cell development.

Happy to share the preprints of two complimentary studies from my Postdoc with @bloodgenes: We set out to understand the mechanisms underlying inherited childhood B cell lymphoblastic leukemia (B-ALL): biorxiv.org/content/10.64898… biorxiv.org/content/10.64898…

Reposting: My lab has an open postdoctoral position to lead large-scale gene association and PheWAS in major biobanks and develop AI/ML models to predict genetic variant function. Strong programming skills, a solid publication record, and human genetics background are required.

Decades of research have revealed the intricacies of how dendritic cells (DCs) function, but fundamental questions remain about how this group of cells develops in humans and how this process goes awry in disease. A thread on our new work! (1/9) biorxiv.org/content/10.64898…